Meta-Analysis of Initial Natriuretic Peptides in the Setting of Sepsis-Induced Myocardial Dysfunction

References

• Singer M , DeutschmanCS, SeymourCWet al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA315(8), 801–810 (2016).
   PubMed Web of Science ®Google Scholar
• Rudd KE , JohnsonSC, AgesaKMet al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet395(10219), 200–211 (2020).
   PubMed Web of Science ®Google Scholar
• Vallabhajosyula S , PruthiS, ShahS, WileyBM, MankadSV, JentzerJC. Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock. Anaesth. Intensive Care46(1), 13–24 (2018).
   PubMed Web of Science ®Google Scholar
• Beesley SJ , WeberG, SargeTet al. Septic cardiomyopathy. Crit. Care Med.46(4), 625–634 (2018).
   PubMed Web of Science ®Google Scholar
• Parker MM , ShelhamerJH, BacharachSLet al. Profound but reversible myocardial depression in patients with septic shock. Ann. Intern. Med.100(4), 483–490 (1984).
   PubMed Web of Science ®Google Scholar
• Boissier F , AissaouiN. Septic cardiomyopathy: diagnosis and management. J. Intensive Med.2(1), 8–16 (2022).
   PubMedGoogle Scholar
• Bansal S , VarshneyS, ShrivastavaA. A prospective observational study to determine incidence and outcome of sepsis-induced cardiomyopathy in an intensive care unit. Indian J. Crit. Care Med.26(7), 798–803 (2022).
   PubMed Web of Science ®Google Scholar
• Innocenti F , PalmieriV, StefanoneVTet al. Comparison of troponin I levels versus myocardial dysfunction on prognosis in sepsis. Intern. Emerg. Med.17(1), 223–231 (2021).
   PubMed Web of Science ®Google Scholar
• Lin YM , LeeMC, TohHSet al. Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis. Ann. Intensive Care12(1), 112 (2022).
   PubMed Web of Science ®Google Scholar
• Hanumanthu BKJ , NairAS, KatamreddyAet al. Sepsis-induced cardiomyopathy is associated with higher mortality rates in patients with sepsis. Acute Crit. Care36(3), 215–222 (2021).
   PubMed Web of Science ®Google Scholar
• Carbone F , LiberaleL, PredaA, SchindlerTH, MontecuccoF. Septic cardiomyopathy: from pathophysiology to the clinical setting. Cells11(18), 2833 (2022).
   PubMed Web of Science ®Google Scholar
• Pandompatam G , KashaniK, VallabhajosyulaS. The role of natriuretic peptides in the management, outcomes and prognosis of sepsis and septic shock. Rev. Bras. Ter. Intensiva31(3), 368–378 (2019).
   PubMedGoogle Scholar
• Page MJ , McKenzieJE, BossuytPMet al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, n71 (2021).
   PubMed Web of Science ®Google Scholar
• Wells G , SheaB, O’ConnellDet al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses (2010). https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Modesti PA , ReboldiG, CappuccioFPet al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLOS ONE11(1), e0147601 (2016).
   PubMed Web of Science ®Google Scholar
• Andrade C . Mean difference, standardized mean difference (SMD), and their use in meta-analysis: as simple as it gets. J. Clin. Psychiatry81(5), 20f13681 (2020).
   PubMed Web of Science ®Google Scholar
• Eusebi P . Diagnostic accuracy measures. Cerebrovasc. Dis.36(4), 267–272 (2013).
   PubMed Web of Science ®Google Scholar
• Chen X , LiuX, DongR, ZhangD, QinS. A retrospective observational study of the association between plasma levels of interleukin 8 in 42 patients with sepsis-induced myocardial dysfunction at a single center between 2017 and 2020. Med. Sci. Monit.27, e933065 (2021).
   PubMed Web of Science ®Google Scholar
• Chen Y , ZhangF, YeXet al. Association between gut dysbiosis and sepsis-induced myocardial dysfunction in patients with sepsis or septic shock. Font. Cell. Infect. Microbiol.12, 857035 (2022).
   PubMed Web of Science ®Google Scholar
• Cheng W , LongY, WangH, HanMm W, ZhangJ, CuiN. Role of the mTOR signalling pathway in human sepsis-induced myocardial dysfunction. Can. J. Cardiol.35(7), 875–883 (2019).
   PubMed Web of Science ®Google Scholar
• Huang R , ChenF, ZengA, KeJ, LinS. Serum sestrin2 was lower in septic shock patients with cardiomyopathy. Dis. Markers2022, 1390373 (2022).
   PubMedGoogle Scholar
• Jeong HS , LeeTH, BangCH, KimJH, HongSJ. Risk factors and outcomes of sepsis-induced myocardial dysfunction and stress-induced cardiomyopathy in sepsis or septic shock: a comparative retrospective study. Medicine97(13), e0263 (2018).
   PubMed Web of Science ®Google Scholar
• Li Z , CuiS, GengL. [Value of combined detection of biomarkers in early diagnosis and prognosis of patients with septic myocardial injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue33(4), 443–448 (2021).
   PubMedGoogle Scholar
• Lu NF , JiangL, ZhuBet al. Elevated plasma histone H4 levels are an important risk factor in the development of septic cardiomyopathy. Balkan Med. J.37(2), 72–78 (2020).
   PubMed Web of Science ®Google Scholar
• Meng JB , HuMH, ZhangM, HuGP, ZhangW, HuSJ. The correlation between whole blood copper (Cu), zinc (Zn) levels and Cu/Zn ratio and sepsis-induced left ventricular systolic dysfunction (SILVSD) in patients with septic shock: a single-center prospective observational study. Int. J. Gen. Med.14, 7219–7234 (2021).
   PubMed Web of Science ®Google Scholar
• Narvaez I , CanabalA, MartinCet al. Incidence and evolution of sepsis-induced cardiomyopathy in a cohort of patients with sepsis and septic shock. Med. Intensiva (Engl. Ed.)42(5), 283–291 (2018).
   PubMed Web of Science ®Google Scholar
• Shang N , LiuH, WangNet al. [Establishment and evaluation of clinical diagnostic scoring system for septic cardiomyopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue33(12), 1409–1413 (2021).
   PubMedGoogle Scholar
• Shin DG , KangMK, SeoYBet al. Factors associated with abnormal left ventricular ejection fraction (decreased or increased) in patients with sepsis in the intensive care unit. PLOS ONE15(3), e0229563 (2020).
   PubMed Web of Science ®Google Scholar
• Song J , YaoY, LinS, HeY, ZhuD, ZhongM. Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study. Crit. Care26(1), 220 (2022).
   PubMed Web of Science ®Google Scholar
• Song MJ , LeeSH, LeemAYet al. Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients. Acute Crit. Care35(2), 67–76 (2020).
   PubMed Web of Science ®Google Scholar
• Wang H , GaoYX, WuYN, LiC, DuanJ. Association between plasma adiponectin levels and left ventricular systolic dysfunction in sepsis patients. J. Crit. Care60, 195–201 (2020).
   PubMed Web of Science ®Google Scholar
• Wang L , XieW, LiGet al. Lipocalin 10 as a new prognostic biomarker in sepsis-induced myocardial dysfunction and mortality: a pilot study. Mediators Inflamm.2021, 6616270 (2021).
   PubMed Web of Science ®Google Scholar
• Weng G , TianP, YanX, ChengQ. Altered function of the left ventricle and clinical significance of heart-type fatty acid-binding protein in cardiac dysfunction among patients with sepsis. Exp. Ther. Med.20(5), 58 (2020).
   PubMed Web of Science ®Google Scholar
• Yu J , ZhengR, YangP, WangD. Construction of a predictive model and prognosis of left ventricular systolic dysfunction in patients with sepsis based on the diagnosis using left ventricular global longitudinal strain. J. Intensive Care10(1), 29 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang HM , ZhouGS, ZhangQ, WangXT, LiuDW. [Risk factors and prognosis in critical patients with sepsis-related cardiomyopathy]. Zhonghua Nei Ke Za Zhi61(6), 644–651 (2022).
   PubMedGoogle Scholar
• Yancy CW , JessupM, BozkurtBet al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. J. Am. Coll. Cardiol.70(6), 776–803 (2017).
   PubMed Web of Science ®Google Scholar
• Alataby H , NfonoyimJ, DiazKet al. The levels of lactate, troponin, and N-terminal pro-B-type natriuretic peptide are predictors of mortality in patients with sepsis and septic shock: a retrospective cohort study. Med. Sci. Monit. Basic Res.27, e927834 (2021).
   PubMed Web of Science ®Google Scholar
• Bhandari B , CunninghamJ. The role of brain natriuretic peptide as a prognostic marker for sepsis. Cureus12(7), e8954 (2020).
   PubMed Web of Science ®Google Scholar
• Biswas S , SonejaM, MakkarNet al. N-terminal pro-brain natriuretic peptide is an independent predictor of mortality in patients with sepsis. J. Investig. Med.70(2), 369–375 (2022).
   PubMed Web of Science ®Google Scholar
• Charpentier J , LuytCE, FullaYet al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med.32(3), 660–665 (2004).
   PubMed Web of Science ®Google Scholar
• Rivers EP , McCordJ, OteroR, JacobsenG, LoombaM. Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. J. Intensive Care Med.22(6), 363–373 (2007).
   PubMedGoogle Scholar
• Klouche K , PommetS, AmiguesLet al. Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortality. J. Intensive Care Med.29(4), 229–237 (2014).
   PubMed Web of Science ®Google Scholar